Report Detail
Global Cancer Drug Therapy Market Professional Survey Report 2019
- RnM3743926 |
- 13 September, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Kidney cancer or renal cancer is one of the ten most frequently diagnosed cancers, found mainly in people aged 60 or above. According to the estimates of the American Cancer Society (ACS), 61,560 new kidney cancer cases and 14,080 deaths would occur in 2015. Due to the increasing prevalence with no cure of this deadly disease, till date, there is an imminent need for effective kidney cancer drugs.
The renal cancer drug therapy market has witnessed a dramatic change in its treatment paradigm over the last three decades. Although, there are a variety of treatment options available, innovators have now shifted their focus towards more targeted therapies and immunotherapies. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors boosting the growth of the market. Strong pipeline and fast-emerging treatments are expected to further boost the market during the analysis period. However, high cost of drugs, looming off-patents and uncertain reimbursement policies are some of the factors that are likely to restrain the market growth.
Winning a physicians confidence regarding the cost, efficacy and dosage would lead to a higher acceptance of drugs in the market. Additionally, immunotherapies would emerge as an opportunity for innovators in the kidney cancer drugs market. Furthermore, untapped geographies with a high undiagnosed patient base would offer lucrative opportunities for the innovators in future. However, overcoming the generic drugs competition would be a key challenge for the leading innovators.
The global Cancer Drug Therapy market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Cancer Drug Therapy volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Drug Therapy market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cancer Drug Therapy in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cancer Drug Therapy manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Amgen / Allergan
Argos Therapeutics
AstraZeneca
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Merck
Roche
Bristol-Myers Squibb
Eisai
Exelixis
Genentech (Roche)
Novartis
Pfizer
Prometheus Labs
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Targeted Therapy
Chemotherapy
Immunotherapy
Segment by Application
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
Table of Contents
Executive Summary
1 Industry Overview of Cancer Drug Therapy
- 1.1 Definition of Cancer Drug Therapy
- 1.2 Cancer Drug Therapy Segment by Type
- 1.2.1 Global Cancer Drug Therapy Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Targeted Therapy
- 1.2.3 Chemotherapy
- 1.2.4 Immunotherapy
- 1.3 Cancer Drug Therapy Segment by Applications
- 1.3.1 Global Cancer Drug Therapy Consumption Comparison by Applications (2014-2025)
- 1.3.2 Angiogenesis Inhibitors
- 1.3.3 mTOR Inhibitors
- 1.3.4 Monoclonal Antibodies
- 1.3.5 Cytokine Immunotherapy (IL-2)
- 1.4 Global Cancer Drug Therapy Overall Market
- 1.4.1 Global Cancer Drug Therapy Revenue (2014-2025)
- 1.4.2 Global Cancer Drug Therapy Production (2014-2025)
- 1.4.3 North America Cancer Drug Therapy Status and Prospect (2014-2025)
- 1.4.4 Europe Cancer Drug Therapy Status and Prospect (2014-2025)
- 1.4.5 China Cancer Drug Therapy Status and Prospect (2014-2025)
- 1.4.6 Japan Cancer Drug Therapy Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Cancer Drug Therapy Status and Prospect (2014-2025)
- 1.4.8 India Cancer Drug Therapy Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Cancer Drug Therapy
- 2.3 Manufacturing Process Analysis of Cancer Drug Therapy
- 2.4 Industry Chain Structure of Cancer Drug Therapy
3 Development and Manufacturing Plants Analysis of Cancer Drug Therapy
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Cancer Drug Therapy Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Cancer Drug Therapy
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Cancer Drug Therapy Production and Capacity Analysis
- 4.2 Cancer Drug Therapy Revenue Analysis
- 4.3 Cancer Drug Therapy Price Analysis
- 4.4 Market Concentration Degree
5 Cancer Drug Therapy Regional Market Analysis
- 5.1 Cancer Drug Therapy Production by Regions
- 5.1.1 Global Cancer Drug Therapy Production by Regions
- 5.1.2 Global Cancer Drug Therapy Revenue by Regions
- 5.2 Cancer Drug Therapy Consumption by Regions
- 5.3 North America Cancer Drug Therapy Market Analysis
- 5.3.1 North America Cancer Drug Therapy Production
- 5.3.2 North America Cancer Drug Therapy Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Cancer Drug Therapy Import and Export
- 5.4 Europe Cancer Drug Therapy Market Analysis
- 5.4.1 Europe Cancer Drug Therapy Production
- 5.4.2 Europe Cancer Drug Therapy Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Cancer Drug Therapy Import and Export
- 5.5 China Cancer Drug Therapy Market Analysis
- 5.5.1 China Cancer Drug Therapy Production
- 5.5.2 China Cancer Drug Therapy Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Cancer Drug Therapy Import and Export
- 5.6 Japan Cancer Drug Therapy Market Analysis
- 5.6.1 Japan Cancer Drug Therapy Production
- 5.6.2 Japan Cancer Drug Therapy Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Cancer Drug Therapy Import and Export
- 5.7 Southeast Asia Cancer Drug Therapy Market Analysis
- 5.7.1 Southeast Asia Cancer Drug Therapy Production
- 5.7.2 Southeast Asia Cancer Drug Therapy Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Cancer Drug Therapy Import and Export
- 5.8 India Cancer Drug Therapy Market Analysis
- 5.8.1 India Cancer Drug Therapy Production
- 5.8.2 India Cancer Drug Therapy Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Cancer Drug Therapy Import and Export
6 Cancer Drug Therapy Segment Market Analysis (by Type)
- 6.1 Global Cancer Drug Therapy Production by Type
- 6.2 Global Cancer Drug Therapy Revenue by Type
- 6.3 Cancer Drug Therapy Price by Type
7 Cancer Drug Therapy Segment Market Analysis (by Application)
- 7.1 Global Cancer Drug Therapy Consumption by Application
- 7.2 Global Cancer Drug Therapy Consumption Market Share by Application (2014-2019)
8 Cancer Drug Therapy Major Manufacturers Analysis
- 8.1 Amgen / Allergan
- 8.1.1 Amgen / Allergan Cancer Drug Therapy Production Sites and Area Served
- 8.1.2 Amgen / Allergan Product Introduction, Application and Specification
- 8.1.3 Amgen / Allergan Cancer Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Argos Therapeutics
- 8.2.1 Argos Therapeutics Cancer Drug Therapy Production Sites and Area Served
- 8.2.2 Argos Therapeutics Product Introduction, Application and Specification
- 8.2.3 Argos Therapeutics Cancer Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 AstraZeneca
- 8.3.1 AstraZeneca Cancer Drug Therapy Production Sites and Area Served
- 8.3.2 AstraZeneca Product Introduction, Application and Specification
- 8.3.3 AstraZeneca Cancer Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Aveo Pharmaceuticals
- 8.4.1 Aveo Pharmaceuticals Cancer Drug Therapy Production Sites and Area Served
- 8.4.2 Aveo Pharmaceuticals Product Introduction, Application and Specification
- 8.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Bayer
- 8.5.1 Bayer Cancer Drug Therapy Production Sites and Area Served
- 8.5.2 Bayer Product Introduction, Application and Specification
- 8.5.3 Bayer Cancer Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Exelixis
- 8.6.1 Exelixis Cancer Drug Therapy Production Sites and Area Served
- 8.6.2 Exelixis Product Introduction, Application and Specification
- 8.6.3 Exelixis Cancer Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Incyte
- 8.7.1 Incyte Cancer Drug Therapy Production Sites and Area Served
- 8.7.2 Incyte Product Introduction, Application and Specification
- 8.7.3 Incyte Cancer Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Merck
- 8.8.1 Merck Cancer Drug Therapy Production Sites and Area Served
- 8.8.2 Merck Product Introduction, Application and Specification
- 8.8.3 Merck Cancer Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Roche
- 8.9.1 Roche Cancer Drug Therapy Production Sites and Area Served
- 8.9.2 Roche Product Introduction, Application and Specification
- 8.9.3 Roche Cancer Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Bristol-Myers Squibb
- 8.10.1 Bristol-Myers Squibb Cancer Drug Therapy Production Sites and Area Served
- 8.10.2 Bristol-Myers Squibb Product Introduction, Application and Specification
- 8.10.3 Bristol-Myers Squibb Cancer Drug Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Eisai
- 8.12 Exelixis
- 8.13 Genentech (Roche)
- 8.14 Novartis
- 8.15 Pfizer
- 8.16 Prometheus Labs
9 Development Trend of Analysis of Cancer Drug Therapy Market
- 9.1 Global Cancer Drug Therapy Market Trend Analysis
- 9.1.1 Global Cancer Drug Therapy Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Cancer Drug Therapy Regional Market Trend
- 9.2.1 North America Cancer Drug Therapy Forecast 2019-2025
- 9.2.2 Europe Cancer Drug Therapy Forecast 2019-2025
- 9.2.3 China Cancer Drug Therapy Forecast 2019-2025
- 9.2.4 Japan Cancer Drug Therapy Forecast 2019-2025
- 9.2.5 Southeast Asia Cancer Drug Therapy Forecast 2019-2025
- 9.2.6 India Cancer Drug Therapy Forecast 2019-2025
- 9.3 Cancer Drug Therapy Market Trend (Product Type)
- 9.4 Cancer Drug Therapy Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Cancer Drug Therapy Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Cancer Drug Therapy. Industry analysis & Market Report on Cancer Drug Therapy is a syndicated market report, published as Global Cancer Drug Therapy Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Cancer Drug Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
